Cargando…

LncRNA LBX2-AS1 impacts osteosarcoma sensitivity to JQ-1 by sequestering miR-597-3p away from BRD4

OBJECTIVE: Recent knowledge concerning the significance of long non-coding RNA (lncRNA)-mediated ceRNA networks provides new insight into their possible roles as specific biomarkers for the treatment of osteosarcoma (OS). Thus, this study aims to clarify the functional relevance and mechanistic acti...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jiayu, Yuan, Xuhui, Ma, Cong, Li, Junhong, Qu, Gaoyang, Yu, Bo, Cai, Feng, Peng, Yuanxiang, Liu, Lang, Zeng, Duo, Jiao, QuanHui, Zhang, Jiongfeng, Luo, Xiaohui, Liao, Qi, Lv, Xiao-Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079882/
https://www.ncbi.nlm.nih.gov/pubmed/37035213
http://dx.doi.org/10.3389/fonc.2023.1139588
_version_ 1785020802392915968
author Li, Jiayu
Yuan, Xuhui
Ma, Cong
Li, Junhong
Qu, Gaoyang
Yu, Bo
Cai, Feng
Peng, Yuanxiang
Liu, Lang
Zeng, Duo
Jiao, QuanHui
Zhang, Jiongfeng
Luo, Xiaohui
Liao, Qi
Lv, Xiao-Bin
author_facet Li, Jiayu
Yuan, Xuhui
Ma, Cong
Li, Junhong
Qu, Gaoyang
Yu, Bo
Cai, Feng
Peng, Yuanxiang
Liu, Lang
Zeng, Duo
Jiao, QuanHui
Zhang, Jiongfeng
Luo, Xiaohui
Liao, Qi
Lv, Xiao-Bin
author_sort Li, Jiayu
collection PubMed
description OBJECTIVE: Recent knowledge concerning the significance of long non-coding RNA (lncRNA)-mediated ceRNA networks provides new insight into their possible roles as specific biomarkers for the treatment of osteosarcoma (OS). Thus, this study aims to clarify the functional relevance and mechanistic actions of lncRNA LBX2-AS1 in OS. METHODS: Differential analysis was performed by integrating the TCGA and GTEx databases. Cox regression analysis was then employed to assess the prognostic value of the model. The expression of lncRNA LBX2-AS1 and miR-597-3p was quantified in OS cell lines by qRT-PCR. The proliferation, migration, invasion, and apoptosis of OS cell lines in response to manipulated lncRNA LBX2-AS1 were evaluated by MTT, colony formation, transwell, Western blot, and flow cytometry assays. Luciferase activity was assayed to validate the reciprocal regulation between lncRNA LBX2-AS1 and miR-597-3p. The protein levels of BRD4 and EMT-related factors were examined by Western blot assay. Finally, tumor growth in response to LBX2-AS1 knockdown was evaluated in xenograft-bearing nude mice. RESULTS: By integrating the GTEx and TCGA databases, we identified 153 differentially expressed lncRNAs. Among them, 5 lncRNAs, RP11-535M15.1, AC002398.12, RP3-355L5.4, LBX2-AS1, and RP11.47A8.5, were selected to establish a model, which predicted the prognosis of OS. Higher lncRNA LBX2-AS1 expression was noted in OS tissues relative to that in normal tissues. Silencing lncRNA LBX2-AS1 facilitated apoptosis and curtailed proliferative, migratory, and invasive capacities of OS cells. Mechanistically, lncRNA LBX2-AS1 could elevate the expression of BRD4, an oncogene, by competitively binding to miR-597-3p. More importantly, knockdown of lncRNA LBX2-AS1 increased the sensitivity of OS cells to the BRD4 inhibitor JQ-1. Finally, the tumor growth of OS cell xenografts was constrained in vivo in the presence of lncRNA LBX2-AS1 knockdown. CONCLUSION: In conclusion, lncRNA LBX2-AS1 promotes the growth of OS and represses the sensitivity to JQ-1 by sponging miR-597-3p to elevate the expression of BRD4.
format Online
Article
Text
id pubmed-10079882
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-100798822023-04-08 LncRNA LBX2-AS1 impacts osteosarcoma sensitivity to JQ-1 by sequestering miR-597-3p away from BRD4 Li, Jiayu Yuan, Xuhui Ma, Cong Li, Junhong Qu, Gaoyang Yu, Bo Cai, Feng Peng, Yuanxiang Liu, Lang Zeng, Duo Jiao, QuanHui Zhang, Jiongfeng Luo, Xiaohui Liao, Qi Lv, Xiao-Bin Front Oncol Oncology OBJECTIVE: Recent knowledge concerning the significance of long non-coding RNA (lncRNA)-mediated ceRNA networks provides new insight into their possible roles as specific biomarkers for the treatment of osteosarcoma (OS). Thus, this study aims to clarify the functional relevance and mechanistic actions of lncRNA LBX2-AS1 in OS. METHODS: Differential analysis was performed by integrating the TCGA and GTEx databases. Cox regression analysis was then employed to assess the prognostic value of the model. The expression of lncRNA LBX2-AS1 and miR-597-3p was quantified in OS cell lines by qRT-PCR. The proliferation, migration, invasion, and apoptosis of OS cell lines in response to manipulated lncRNA LBX2-AS1 were evaluated by MTT, colony formation, transwell, Western blot, and flow cytometry assays. Luciferase activity was assayed to validate the reciprocal regulation between lncRNA LBX2-AS1 and miR-597-3p. The protein levels of BRD4 and EMT-related factors were examined by Western blot assay. Finally, tumor growth in response to LBX2-AS1 knockdown was evaluated in xenograft-bearing nude mice. RESULTS: By integrating the GTEx and TCGA databases, we identified 153 differentially expressed lncRNAs. Among them, 5 lncRNAs, RP11-535M15.1, AC002398.12, RP3-355L5.4, LBX2-AS1, and RP11.47A8.5, were selected to establish a model, which predicted the prognosis of OS. Higher lncRNA LBX2-AS1 expression was noted in OS tissues relative to that in normal tissues. Silencing lncRNA LBX2-AS1 facilitated apoptosis and curtailed proliferative, migratory, and invasive capacities of OS cells. Mechanistically, lncRNA LBX2-AS1 could elevate the expression of BRD4, an oncogene, by competitively binding to miR-597-3p. More importantly, knockdown of lncRNA LBX2-AS1 increased the sensitivity of OS cells to the BRD4 inhibitor JQ-1. Finally, the tumor growth of OS cell xenografts was constrained in vivo in the presence of lncRNA LBX2-AS1 knockdown. CONCLUSION: In conclusion, lncRNA LBX2-AS1 promotes the growth of OS and represses the sensitivity to JQ-1 by sponging miR-597-3p to elevate the expression of BRD4. Frontiers Media S.A. 2023-03-24 /pmc/articles/PMC10079882/ /pubmed/37035213 http://dx.doi.org/10.3389/fonc.2023.1139588 Text en Copyright © 2023 Li, Yuan, Ma, Li, Qu, Yu, Cai, Peng, Liu, Zeng, Jiao, Zhang, Luo, Liao and Lv https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Li, Jiayu
Yuan, Xuhui
Ma, Cong
Li, Junhong
Qu, Gaoyang
Yu, Bo
Cai, Feng
Peng, Yuanxiang
Liu, Lang
Zeng, Duo
Jiao, QuanHui
Zhang, Jiongfeng
Luo, Xiaohui
Liao, Qi
Lv, Xiao-Bin
LncRNA LBX2-AS1 impacts osteosarcoma sensitivity to JQ-1 by sequestering miR-597-3p away from BRD4
title LncRNA LBX2-AS1 impacts osteosarcoma sensitivity to JQ-1 by sequestering miR-597-3p away from BRD4
title_full LncRNA LBX2-AS1 impacts osteosarcoma sensitivity to JQ-1 by sequestering miR-597-3p away from BRD4
title_fullStr LncRNA LBX2-AS1 impacts osteosarcoma sensitivity to JQ-1 by sequestering miR-597-3p away from BRD4
title_full_unstemmed LncRNA LBX2-AS1 impacts osteosarcoma sensitivity to JQ-1 by sequestering miR-597-3p away from BRD4
title_short LncRNA LBX2-AS1 impacts osteosarcoma sensitivity to JQ-1 by sequestering miR-597-3p away from BRD4
title_sort lncrna lbx2-as1 impacts osteosarcoma sensitivity to jq-1 by sequestering mir-597-3p away from brd4
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079882/
https://www.ncbi.nlm.nih.gov/pubmed/37035213
http://dx.doi.org/10.3389/fonc.2023.1139588
work_keys_str_mv AT lijiayu lncrnalbx2as1impactsosteosarcomasensitivitytojq1bysequesteringmir5973pawayfrombrd4
AT yuanxuhui lncrnalbx2as1impactsosteosarcomasensitivitytojq1bysequesteringmir5973pawayfrombrd4
AT macong lncrnalbx2as1impactsosteosarcomasensitivitytojq1bysequesteringmir5973pawayfrombrd4
AT lijunhong lncrnalbx2as1impactsosteosarcomasensitivitytojq1bysequesteringmir5973pawayfrombrd4
AT qugaoyang lncrnalbx2as1impactsosteosarcomasensitivitytojq1bysequesteringmir5973pawayfrombrd4
AT yubo lncrnalbx2as1impactsosteosarcomasensitivitytojq1bysequesteringmir5973pawayfrombrd4
AT caifeng lncrnalbx2as1impactsosteosarcomasensitivitytojq1bysequesteringmir5973pawayfrombrd4
AT pengyuanxiang lncrnalbx2as1impactsosteosarcomasensitivitytojq1bysequesteringmir5973pawayfrombrd4
AT liulang lncrnalbx2as1impactsosteosarcomasensitivitytojq1bysequesteringmir5973pawayfrombrd4
AT zengduo lncrnalbx2as1impactsosteosarcomasensitivitytojq1bysequesteringmir5973pawayfrombrd4
AT jiaoquanhui lncrnalbx2as1impactsosteosarcomasensitivitytojq1bysequesteringmir5973pawayfrombrd4
AT zhangjiongfeng lncrnalbx2as1impactsosteosarcomasensitivitytojq1bysequesteringmir5973pawayfrombrd4
AT luoxiaohui lncrnalbx2as1impactsosteosarcomasensitivitytojq1bysequesteringmir5973pawayfrombrd4
AT liaoqi lncrnalbx2as1impactsosteosarcomasensitivitytojq1bysequesteringmir5973pawayfrombrd4
AT lvxiaobin lncrnalbx2as1impactsosteosarcomasensitivitytojq1bysequesteringmir5973pawayfrombrd4